MAPT and Alzheimer disease: Here, in this study we measured plasma NDEV levels of Aβ42, total tau, P-T181-tau, P-S396-tau, NRGN, and REST in 116 patients with mild to moderately severe AD and in 20 cognitively normal control subjects.